197067530	197067530	CD	B-NP	O
|	|	NN	I-NP	O
CCHO	CCHO	NN	I-NP	O
|	|	NN	I-NP	O
20930664	20930664	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3963531	3963531	CD	B-NP	O
|	|	CC	I-NP	O
3/24/2006	3/24/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
s/p	s/p	NN	I-NP	O
mechanical	mechanical	JJ	I-NP	O
fall	fall	NN	I-NP	O
,	,	,	O	O
|	|	NNP	B-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/29/2006	5/29/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/18/2006	4/18/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
HEMRICH	HEMRICH	NN	B-NP	O
,	,	,	O	O
NOBLE	NOBLE	NN	B-NP	O
657-85-93-4	657-85-93-4	CD	I-NP	O
Por	Por	NNP	I-NP	O
Olu	Olu	NNP	I-NP	O
Naeans	Naeans	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
4/15/06	4/15/06	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BOLSTAD	BOLSTAD	NNP	B-NP	O
,	,	,	O	O
CLEMENTE	CLEMENTE	NNP	B-NP	O
ARMAND	ARMAND	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
,	,	,	O	O
Headache	Headache	NNP	B-NP	O
AMIODARONE	AMIODARONE	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/15/06	4/15/06	CD	B-NP	O
by	by	IN	B-PP	O
GREINKE	GREINKE	NNP	B-NP	O
,	,	,	O	O
LAMONT	LAMONT	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
PA	PA	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
804350162	804350162	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitoring	monitor	VBG	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/26/06	1/26/06	CD	B-NP	O
by	by	IN	B-PP	O
RELYEA	RELYEA	NNP	B-NP	O
,	,	,	O	O
ROCKY	ROCKY	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
PA	PA	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
213873292	213873292	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitor	monitor	VB	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/5/06	8/5/06	CD	B-NP	O
by	by	IN	B-PP	O
RODGERS	RODGERS	NNS	B-NP	O
,	,	,	O	O
CLARENCE	CLARENCE	NN	B-NP	O
CARMINE	CARMINE	NN	I-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
397917160	397917160	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/28/06	10/28/06	CD	B-NP	O
by	by	IN	B-PP	O
PETRONE	PETRONE	NNP	B-NP	O
,	,	,	O	O
EDDY	EDDY	NNP	B-NP	O
DALTON	DALTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
604552840	604552840	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/28/06	10/28/06	CD	B-NP	O
by	by	IN	B-PP	O
FRANDEEN	FRANDEEN	NN	B-NP	O
,	,	,	O	O
FRANKIE	FRANKIE	NNP	B-NP	O
PETER	PETER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
622537698	622537698	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/20/06	7/20/06	CD	B-NP	O
by	by	IN	B-PP	O
MONNERJAHN	MONNERJAHN	NN	B-NP	O
,	,	,	O	O
VANCE	VANCE	NN	B-NP	O
,	,	,	O	O
PA-C	PA-C	NN	B-NP	B-protein
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
435496666	435496666	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitor	monitor	NN	B-NP	O
INR	INR	NNP	I-NP	O
NATURAL	NATURAL	NNP	I-NP	O
TEARS	TEARS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ARTIFICIAL	ARTIFICIAL	NNP	I-NP	O
TEARS	TEARS	VBZ	B-VP	O
-RRB-	-RRB-	NNP	B-NP	B-protein
2	2	CD	I-NP	I-protein
DROP	DROP	NNP	I-NP	I-protein
OU	OU	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
COLACE	COLACE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
PLAQUENIL	PLAQUENIL	NNP	I-NP	I-protein
SULFATE	SULFATE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
HYDROXYCHLOROQUINE	HYDROXYCHLOROQUINE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
200	200	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	B-protein
ISORDIL	ISORDIL	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	I-protein
DINITRATE	DINITRATE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
110	110	CD	B-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
20	20	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	I-protein
110	110	CD	B-NP	I-protein
MILK	MILK	NN	I-NP	I-protein
OF	OF	IN	B-PP	O
MAGNESIA	MAGNESIA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MAGNESIUM	MAGNESIUM	NNP	I-NP	O
HYDROXIDE	HYDROXIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MILLILITERS	MILLILITERS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
coumadin	coumadin	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
5mg	5mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
alternating	alternate	VBG	B-VP	O
days	day	NNS	B-NP	O
-LRB-	-LRB-	SYM	O	O
5mg	5mg	NN	B-NP	O
3d/wk	3d/wk	CD	I-NP	O
;	;	:	O	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
4d/wk	4d/wk	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/15/06	4/15/06	CD	B-NP	O
by	by	IN	B-PP	O
DANCY	DANCY	NNP	B-NP	O
,	,	,	O	O
GERARD	GERARD	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
PA	PA	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitoring	monitor	VBG	B-VP	O
NORVASC	NORVASC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
110	110	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

NEURONTIN	NEURONTIN	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
GABAPENTIN	GABAPENTIN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
300	300	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
NEXIUM	NEXIUM	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
MAALOX-TABLETS	MAALOX-TABLETS	NNP	I-NP	I-protein
QUICK	QUICK	NNP	I-NP	I-protein
DISSOLVE/CHEWABLE	DISSOLVE/CHEWABLE	NNP	I-NP	I-protein
1-2	1-2	NN	I-NP	I-protein
TAB	TAB	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Upset	Upset	NNP	I-NP	O
Stomach	Stomach	NNP	I-NP	O
DULCOLAX	DULCOLAX	NNP	I-NP	O
RECTAL	RECTAL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BISACODYL	BISACODYL	NNP	I-NP	O
RECTAL	RECTAL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PR	PR	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
CLOTRIMAZOLE	CLOTRIMAZOLE	NNP	I-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
apply	apply	VB	B-VP	O
to	to	TO	I-VP	O
feet	feet	VB	I-VP	O
bilat	bilat	NN	B-NP	O
GLYBURIDE	GLYBURIDE	NNP	B-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/15/06	4/15/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
GLYBURIDE	GLYBURIDE	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	O
949162531	949162531	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
regularly	regularly	RB	B-ADVP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	B-DNA
LASIX	LASIX	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
FUROSEMIDE	FUROSEMIDE	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
Today	Today	NNP	I-NP	I-DNA
February	February	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
40	40	CD	B-NP	O
daily	daily	RB	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
yet	yet	RB	B-ADVP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
renal	renal	JJ	B-NP	O
insuff	insuff	NN	I-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
renal	renal	JJ	B-NP	O
fx	fx	NN	I-NP	O
corrected	correct	VBD	B-VP	O
pt	pt	NN	B-NP	O
restarted	restart	VBD	B-VP	O
on	on	IN	B-PP	O
lasix	lasix	CD	B-NP	O
20	20	CD	I-NP	O
qd	qd	NN	I-NP	O
on	on	IN	B-PP	O
d/c	d/c	NN	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/15/06	4/15/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
408582195	408582195	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitored	monitor	VBN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	I-NP	O
NAS	NAS	NN	I-NP	B-protein
/	/	SYM	I-NP	O
Carbohydrate	Carbohydrate	NN	I-NP	O
Controlled	Control	VBN	B-VP	O
/	/	SYM	B-NP	B-protein
Low	Low	NN	I-NP	I-protein
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
per	per	IN	B-PP	O
physical	physical	JJ	B-NP	B-cell_type
therapy	therapy	NN	I-NP	I-cell_type
recs	rec	NNS	I-NP	I-cell_type
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Mcnichol	Mcnichol	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MH	MH	NNP	I-NP	O
MD	MD	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
051-469-9935	051-469-9935	CD	I-NP	O
10/27	10/27	CD	I-NP	O
@	@	NN	I-NP	O
8	8	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Jacob	Jacob	NNP	I-NP	O
Hainer	Hainer	NNP	I-NP	O
in	in	IN	B-PP	O
SONMEN	SONMEN	NNP	B-NP	O
'S	'S	NNP	I-NP	O
COMMUNITY	COMMUNITY	NNP	I-NP	O
MEMORIAL	MEMORIAL	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Dr	Dr	NNP	I-NP	O
Krag	Krag	NNP	I-NP	O
is	be	VBZ	B-VP	O
away	away	RB	B-ADVP	O
-RRB-	-RRB-	IN	B-PP	O
151-063-4396	151-063-4396	CD	B-NP	O
10/27	10/27	CD	I-NP	O
@	@	SYM	B-NP	O
9	9	CD	I-NP	O
:	:	SYM	I-NP	O
15	15	CD	I-NP	O
,	,	,	O	O
psych	psych	NN	B-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
within	within	IN	B-PP	O
24-48hrs	24-48hr	NNS	B-NP	O
780-184-2650	780-184-2650	CD	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Harty	Harty	NNP	I-NP	O
-	-	:	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
arthritis	arthritis	NN	I-NP	O
center	center	NN	I-NP	O
Cean	Cean	NNP	I-NP	O
Rockca	Rockca	NNP	I-NP	O
683-430-0751	683-430-0751	CD	I-NP	O
4/2	4/2	CD	I-NP	O
@	@	NN	I-NP	O
3	3	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
11/14/06	11/14/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Stanko	Stanko	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PCP	PCP	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
QUININE	QUININE	NNP	B-NP	O
,	,	,	O	O
Aspirin	Aspirin	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
s/p	s/p	NN	B-NP	O
mech	mech	NN	I-NP	O
fall	fall	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
mechanical	mechanical	JJ	I-NP	O
fall	fall	NN	I-NP	O
,	,	,	O	O
OTHER	OTHER	NNP	B-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
St.	St.	NNP	I-NP	O
Jude	Jude	NNP	I-NP	O
MVR	MVR	NNP	I-NP	O
for	for	IN	B-PP	O
MS	MS	NNP	B-NP	O
,	,	,	O	O
Hx	Hx	NNP	B-NP	O
AFib/flutter	AFib/flutter	NNP	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
IMI	IMI	NNP	I-NP	O
,	,	,	O	O
NIDDM	NIDDM	NNP	B-NP	O
,	,	,	O	O
gout	gout	IN	B-PP	O
Hx	Hx	NNP	B-NP	O
DVT	DVT	NNP	I-NP	O
'70	'70	CD	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
appy	appy	JJ	I-NP	O
,	,	,	I-NP	O
s/p	s/p	JJ	I-NP	O
umbilical	umbilical	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
sigmoidectomy	sigmoidectomy	NN	I-NP	O
for	for	IN	B-PP	O
diverticulitis	diverticulitis	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
L	L	NN	I-NP	I-protein
hip	hip	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
'95	'95	CD	I-NP	I-protein
,	,	,	O	O
PE	PE	NN	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
block	block	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
third	third	JJ	I-NP	O
degree	degree	NN	I-NP	O
heart	heart	NN	I-NP	O
block	block	VBP	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
DDD	DDD	NN	I-NP	O
pacer	pacer	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
fall	fall	NN	B-NP	O
--	--	:	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
83	83	CD	B-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
hx	hx	NN	B-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
Afib/aflutter	Afib/aflutter	NN	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
block	block	VBP	B-VP	O
s/p	s/p	NN	B-NP	O
pacer	pacer	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
St.	St.	NNP	I-NP	O
Judes	Judes	NNP	I-NP	O
MVR	MVR	NNP	I-NP	O
,	,	,	O	O
NIDDM	NIDDM	NNP	B-NP	O
,	,	,	O	O
hx	hx	NN	B-NP	O
PE	PE	NNP	I-NP	O
,	,	,	O	O
hx	hx	NN	B-NP	B-protein
L	L	NN	I-NP	I-protein
hip	hip	NN	I-NP	I-protein
fx	fx	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
screws	screw	NNS	I-NP	I-protein
since	since	IN	B-SBAR	I-protein
removed	remove	VBN	B-VP	I-protein
who	who	WP	B-NP	I-protein
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
fall	fall	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
reportedly	reportedly	RB	I-VP	O
trying	try	VBG	I-VP	O
to	to	TO	I-VP	O
open	open	VB	I-VP	O
her	her	PRP$	B-NP	O
closet	closet	NN	I-NP	O
door	door	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
suprised	suprise	VBN	I-VP	O
to	to	TO	I-VP	O
realize	realize	VB	I-VP	O
the	the	DT	B-NP	O
door	door	NN	I-NP	O
was	be	VBD	B-VP	O
already	already	RB	B-ADVP	O
ajar	ajar	NN	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
falling	falling	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
closet	closet	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
get	get	VB	I-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

She	She	PRP	B-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
hit	hit	VBD	B-VP	O
her	her	PRP	B-NP	O
``	``	``	O	O
whole	whole	JJ	B-NP	O
body	body	NN	I-NP	O
''	''	''	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
fell	fall	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lay	lie	VBD	B-VP	O
there	there	RB	B-ADVP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
night	night	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
crawl	crawl	VB	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
closet	closet	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
son	son	NN	I-NP	O
was	be	VBD	B-VP	O
concerned	concern	VBN	I-VP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
n't	n't	RB	I-VP	O
answer	answer	VB	I-VP	O
the	the	DT	B-NP	O
phone	phone	NN	I-NP	O
and	and	CC	O	O
called	call	VBD	B-VP	O
the	the	DT	B-NP	O
police	police	NN	I-NP	O
who	who	WP	B-NP	O
found	find	VBD	B-VP	O
her	her	PRP	B-NP	O
lying	lie	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
complained	complain	VBD	B-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
of	of	IN	B-PP	O
L	L	NN	B-NP	B-protein
shoulder	shoulder	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
bilat	bilat	JJ	B-NP	O
Knee	Knee	NNP	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
L	L	NN	B-NP	O
pubic/pelvis	pubic/pelvis	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
otherwise	otherwise	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
for	for	IN	B-PP	O
syncope	syncope	NN	B-NP	O
,	,	,	O	O
LOC	LOC	NN	B-NP	B-protein
,	,	,	O	O
CP	CP	NN	B-NP	B-DNA
,	,	,	O	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
F/C	F/C	NN	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
troponin	troponin	NN	B-NP	O
leak	leak	NN	I-NP	O
of	of	IN	B-PP	O
0.23	0.23	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
films	film	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
except	except	IN	B-PP	O
pelvis	pelvis	NN	B-NP	O
XRY	XRY	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
pubic	pubic	JJ	B-NP	O
ramus	ramus	NN	I-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
Data	Data	NN	B-NP	O
:	:	:	O	O
EKG	EKG	NN	B-NP	O
:	:	:	O	O
Prolonged	Prolonged	JJ	B-NP	O
QT	QT	NN	I-NP	O
interval	interval	NN	I-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADJP	O
unchanged	unchanged	JJ	I-ADJP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
neg	neg	NN	B-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
cardiopulm	cardiopulm	NN	I-NP	O
dz	dz	NN	I-NP	O
Head	Head	NNP	I-NP	O
CT	CT	NNP	I-NP	O
:	:	:	O	O
neg	neg	NN	B-NP	O
Cspine	Cspine	NN	I-NP	O
CT	CT	NN	I-NP	O
:	:	:	O	O
neg	neg	NN	B-NP	O
L	L	NN	I-NP	O
shoulder	shoulder	NN	I-NP	O
film	film	NN	I-NP	O
:	:	:	O	O
neg	neg	NN	B-NP	O
Bilat	Bilat	NN	I-NP	O
knee	knee	NN	I-NP	O
film	film	NN	I-NP	O
:	:	:	O	O
neg	neg	NN	B-NP	O
Pelvis	Pelvis	NNP	I-NP	O
XRY	XRY	NNP	I-NP	O
:	:	:	O	O
?	?	.	O	O

pubic	pubic	JJ	B-NP	B-protein
ramus	ramus	NN	I-NP	I-protein
fracture	fracture	NN	I-NP	I-protein
Labs	Lab	NNS	I-NP	I-protein
:	:	:	O	O
*	*	SYM	B-NP	O
Na	Na	NN	B-NP	O
146	146	CD	I-NP	O
,	,	,	O	O
*	*	SYM	B-NP	B-DNA
CK	CK	NN	B-NP	I-DNA
3320	3320	CD	I-NP	I-DNA
,	,	,	O	O
*	*	SYM	B-NP	B-cell_line
CKMB	CKMB	NN	B-NP	I-cell_line
12.9	12.9	CD	I-NP	I-cell_line
,	,	,	O	O
*	*	SYM	B-NP	O
Trop	Trop	NN	B-NP	O
0.23	0.23	CD	I-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
0.10	0.10	CD	B-NP	O
.	.	.	O	O

*	*	SYM	O	O
AST	AST	NN	B-NP	O
107	107	CD	I-NP	O
Cr	Cr	NNP	I-NP	O
:	:	:	O	O
1.2	1.2	CD	B-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
1.6	1.6	CD	I-NP	O
--	--	:	O	O
Medications	Medication	NNS	B-NP	O
on	on	IN	B-PP	O
Admission	Admission	NN	B-NP	O
:	:	:	O	O
Amiodarone	Amiodarone	NN	B-NP	O
100	100	CD	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	I-NP	O
Colace	Colace	NNP	I-NP	O
100	100	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
lasix	lasix	CD	B-NP	O
40mg	40mg	NN	I-NP	O
QD	QD	NNP	B-NP	O
,	,	,	O	O
Glyburide	Glyburide	NNP	B-NP	O
5mg	5mg	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Plaquenil	Plaquenil	NNP	B-NP	O
200mg	200mg	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
20mg	20mg	NN	I-NP	O
tid	tid	NN	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
20mg	20mg	NNP	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NNP	B-NP	O
5mg	5mg	CD	B-NP	O
3dys/week	3dys/week	CD	I-NP	O
,	,	,	O	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
4dys/week	4dys/week	NN	I-NP	O
,	,	,	O	O
Norvasc	Norvasc	NNP	B-NP	O
10mg	10mg	CD	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
Neurontin	Neurontin	NNP	B-NP	O
300mg	300mg	NNP	I-NP	O
TID	TID	NNP	I-NP	O
--	--	:	O	O
ALL	ALL	NN	B-NP	O
:	:	:	O	O
Quinine-hypotension	Quinine-hypotension	NN	B-NP	O
&	&	CC	I-NP	O
syncope	syncope	NN	I-NP	O
,	,	,	O	O
PCN-rash	PCN-rash	NN	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Asa-rash	Asa-rash	NNP	B-NP	O
--	--	:	O	O
PMH	PMH	NN	B-NP	O
:	:	:	O	O
See	See	VB	B-VP	O
list	list	NN	B-NP	O
--	--	:	O	O
Exam	Exam	NN	B-NP	O
on	on	IN	B-PP	O
Admit	Admit	NNP	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	B-protein
98.5	98.5	CD	I-NP	I-protein
,	,	,	O	O
HR	HR	NN	B-NP	O
60-64	60-64	CD	I-NP	O
,	,	,	O	O
RR	RR	NN	B-NP	O
16-18	16-18	CD	I-NP	O
,	,	,	O	O
BP	BP	NNP	B-NP	O
149-155/58	149-155/58	CD	I-NP	O
-81	-81	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2L	2L	NN	B-NP	O
GEN	GEN	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
stated	state	VBN	B-NP	O
age	age	NN	I-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
L	L	NN	B-NP	O
eye	eye	NN	I-NP	O
not	not	RB	O	O
opening	open	VBG	B-VP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
way	way	NN	I-NP	O
.	.	.	O	O

L	L	NN	B-NP	O
eye	eye	NN	I-NP	O
slightly	slightly	RB	B-NP	O
tender	tender	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
,	,	,	O	O
EOMI	EOMI	NNP	B-NP	O
,	,	,	O	O
PERRLA	PERRLA	NNP	B-NP	O
B	B	NNP	I-NP	O
,	,	,	O	O
Dry	Dry	NNP	B-NP	O
MM	MM	NNP	I-NP	O
NECK	NECK	NNP	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
,	,	,	O	O
No	No	DT	B-NP	O
JVD	JVD	NN	I-NP	O
LUNGS	LUNGS	NN	I-NP	O
:	:	:	O	O
CTA	CTA	NN	B-NP	O
B	B	NN	I-NP	O
HEART	HEART	NN	I-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	O
nrml	nrml	NN	I-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
mechanical	mechanical	JJ	B-NP	O
S2	S2	NN	I-NP	O
ABD	ABD	NN	I-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
NT	NT	NN	I-NP	O
,	,	,	O	O
ND	ND	NN	B-NP	O
EXT	EXT	NN	I-NP	O
:	:	:	O	O
L	L	NN	B-NP	O
shoulder	shoulder	NN	I-NP	O
pain	pain	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
extension	extension	NN	B-NP	O
Hyperkeratosis	Hyperkeratosis	NN	I-NP	O
of	of	IN	B-PP	O
LE	LE	NN	B-NP	O
to	to	TO	B-PP	O
below	below	IN	B-PP	O
knees	knee	NNS	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

L	L	NN	B-NP	O
pelvis	pelvi	VBZ	B-VP	O
tender	tender	NN	B-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

L	L	NN	B-NP	B-protein
leg	leg	NN	I-NP	I-protein
SAR	SAR	NN	I-NP	I-protein
limited	limit	VBN	B-VP	O
by	by	IN	B-PP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
L	L	NN	B-NP	O
pubic	pubic	JJ	I-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

Strength	Strength	NN	B-NP	O
5/5	5/5	CD	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
.	.	.	O	O

--	--	:	B-NP	O
Hospital	Hospital	NNP	I-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

ORTHO	ORTHO	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
s/p	s/p	NN	B-NP	O
fall	fall	NN	I-NP	O
with	with	IN	B-PP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
pelvic	pelvic	JJ	B-NP	O
fracture	fracture	NN	I-NP	O
from	from	IN	B-PP	O
XRY	XRY	NN	B-NP	B-DNA
.	.	.	O	O

Shoulder	Shoulder	NN	B-NP	O
,	,	,	O	O
hip	hip	NN	B-NP	O
,	,	,	O	O
pelvic	pelvic	JJ	B-NP	O
films	film	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
fx	fx	NN	B-NP	O
or	or	CC	I-NP	O
dislocation	dislocation	NN	I-NP	O
except	except	IN	B-PP	O
abnl	abnl	NN	B-NP	O
finding	finding	NN	I-NP	O
R	R	NN	I-NP	O
pelvic	pelvic	JJ	I-NP	O
ramus	ramus	NN	I-NP	O
.	.	.	O	O

Unable	Unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
perform	perform	VB	I-VP	O
MRI	MRI	NN	B-NP	O
2/2	2/2	CD	I-NP	O
valve	valve	NN	I-NP	O
and	and	CC	I-NP	O
pacer	pacer	NN	I-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
pelvis	pelvis	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
pelvic	pelvic	JJ	B-NP	O
fx	fx	NN	I-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
controlled	control	VBN	B-VP	O
with	with	IN	B-PP	O
APAP	APAP	NN	B-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

PT	PT	NN	B-NP	O
consult	consult	NN	I-NP	O
obtained	obtain	VBN	B-VP	O
6/25	6/25	CD	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
daily	daily	RB	B-ADVP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
2	2	CD	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

GYN	GYN	NN	B-NP	B-protein
:	:	:	O	O
CT	CT	NN	B-NP	O
pelvis	pelvis	NN	I-NP	O
did	do	VBD	B-VP	O
show	show	VB	I-VP	O
R	R	NN	B-NP	O
adnexal	adnexal	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
on	on	IN	B-PP	O
prelim	prelim	NN	B-NP	O
read	read	NN	I-NP	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
further	further	JJ	B-NP	O
characterization	characterization	NN	I-NP	O
by	by	IN	B-PP	O
US	US	NNP	B-NP	O
and	and	CC	O	O
outpt	outpt	JJ	B-VP	O
follow	follow	VB	I-VP	O
up	up	IN	B-PRT	O
.	.	.	O	O

--	--	:	O	O
3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

CV	CV	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
extensive	extensive	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
history	history	NN	I-NP	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
fall	fall	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
likely	likely	JJ	B-ADJP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
cardiac	cardiac	JJ	B-NP	O
issue	issue	NN	I-NP	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
mechanical	mechanical	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
syncope	syncope	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	B-NP	O
etc.	etc.	FW	I-NP	O
.	.	.	O	O

ISCHEMIA	ISCHEMIA	NN	B-NP	O
:	:	:	O	O
NSTEMI	NSTEMI	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
small	small	JJ	B-NP	O
TnI	TnI	NN	I-NP	O
leak	leak	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-NP	O
demand	demand	NN	I-NP	O
related	relate	VBN	B-VP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
hypovolemia	hypovolemia	NN	B-NP	O
,	,	,	O	O
fall	fall	NN	B-NP	O
.	.	.	O	O

Enzymes	Enzyme	NNS	B-NP	B-protein
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
.	.	.	O	O

PUMP	PUMP	NN	B-NP	O
:	:	:	O	O
Dry	Dry	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Rehydrated	Rehydrate	VBN	B-VP	O
with	with	IN	B-PP	O
IVF	IVF	NN	B-NP	B-protein
,	,	,	O	O
po	po	NN	B-NP	O
's	's	POS	B-NP	O
encouraged	encouraged	JJ	I-NP	O
.	.	.	O	O

Euvolemic	Euvolemic	JJ	B-ADJP	O
by	by	IN	B-PP	O
10/22	10/22	CD	B-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
up	up	IN	B-PP	O
to	to	TO	B-PP	O
12cm	12cm	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
gauge	gauge	VB	I-VP	O
volume	volume	NN	B-NP	B-protein
status	status	NN	I-NP	I-protein
2/2	2/2	CD	B-NP	I-protein
TR	TR	NN	I-NP	I-protein
.	.	.	O	O

To	To	TO	B-VP	O
recommence	recommence	VB	I-VP	O
lasix	lasix	NN	B-NP	O
at	at	IN	B-PP	O
half	half	JJ	B-NP	O
dose	dose	NN	I-NP	O
2/10	2/10	CD	I-NP	O
.	.	.	O	O

PCP	PCP	NN	B-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
and	and	CC	I-VP	O
titrate	titrate	VB	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
baseline	baseline	NN	I-NP	O
dose	dose	NN	I-NP	O
if	if	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

IVF	IVF	NN	B-NP	O
d/c	d/c	NN	I-NP	O
'd	'd	NN	I-NP	O
.	.	.	O	O

RHYTHM	RHYTHM	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
prolonged	prolong	VBN	I-VP	O
QT	QT	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

Unclear	Unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
?	?	.	O	O

starvation	starvation	NN	B-NP	O
.	.	.	O	O

Monitored	Monitor	VBN	B-VP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
until	until	IN	B-PP	O
ROMI	ROMI	NN	B-NP	B-protein
.	.	.	O	O

Avoided	Avoid	VBN	B-NP	O
drugs	drug	NNS	I-NP	O
that	that	WDT	B-NP	O
confound	confound	VBP	B-VP	O
.	.	.	O	O

Resolved	Resolve	VBN	B-VP	O
to	to	TO	B-PP	O
QTc	QTc	NN	B-NP	B-protein
in	in	IN	B-PP	O
low	low	JJ	B-NP	O
500s	500	NNS	I-NP	O
.	.	.	O	O

DDD	DDD	NN	B-NP	O
pacer	pacer	NN	I-NP	O
functioning	function	VBG	B-VP	O
with	with	IN	B-PP	O
V-pacing	V-pacing	NN	B-NP	O
at	at	IN	B-PP	O
60bpm	60bpm	CD	B-NP	O
--	--	:	O	O
4	4	CD	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
Holding	Hold	VBG	B-VP	O
Glypizide	Glypizide	NN	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

Novolog	Novolog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

Starting	Start	VBG	B-VP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
NPH	NPH	NN	I-NP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
BID	BID	VBN	B-VP	O
on	on	IN	B-PP	O
10/22	10/22	CD	B-NP	O
.	.	.	O	O

Monitored	Monitor	VBN	B-NP	O
FS	FS	NN	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	I-NP	O
adjusted	adjust	VBN	I-NP	O
scale	scale	NN	I-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
5	5	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
for	for	IN	B-PP	O
St.	St.	NNP	B-NP	O
Judes	Judes	NNP	I-NP	O
Valve	Valve	NNP	I-NP	O
,	,	,	O	O
afib/flutter	afib/flutter	JJ	B-NP	O
and	and	CC	I-NP	O
hx	hx	NN	I-NP	O
PEs	PE	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
coumadin	coumadin	NN	B-NP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
two	two	CD	I-NP	O
nights	night	NNS	I-NP	O
before	before	IN	B-PP	O
admission	admission	NN	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
lying	lie	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
s/p	s/p	NN	I-NP	O
fall	fall	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
subtherapeutic	subtherapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Bridged	Bridge	VBN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
lovenox	lovenox	NN	B-NP	O
and	and	CC	I-NP	O
INR	INR	NN	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
10/22	10/22	CD	I-NP	O
and	and	CC	O	O
restarted	restart	VBD	B-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
5/2	5/2	CD	B-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
variable	variable	JJ	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

***	***	SYM	O	O
Needs	Need	NNS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
dosed	dose	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
variable	variable	JJ	B-NP	O
dose	dose	NN	I-NP	O
--	--	:	O	O
6	6	CD	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
pt	pt	NN	I-NP	O
on	on	IN	B-PP	O
80mg	80mg	NN	B-NP	O
lasix	lasix	NN	I-NP	O
daily	daily	RB	B-ADVP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
yet	yet	RB	B-ADJP	O
dry	dry	JJ	I-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
renal	renal	JJ	B-NP	O
fx	fx	NN	I-NP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
lasix	lasix	CD	B-NP	O
held	hold	VBN	B-VP	O
.	.	.	O	O

Restarted	Restart	VBN	B-VP	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	O
20	20	CD	I-NP	O
qd	qd	NN	I-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
d/c	d/c	NN	B-NP	O
-	-	HYPH	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
--	--	:	O	I-protein
7	7	CD	B-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

PPX	PPX	NNP	B-NP	O
Lovenox/coumadin	Lovenox/coumadin	NNP	I-NP	O
--	--	:	O	O
FULL	FULL	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
to	to	TO	B-VP	O
draw	draw	VB	I-VP	O
INR	INR	NN	B-NP	O
Q3	Q3	NN	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
PCP	PCP	NN	B-NP	B-protein
with	with	IN	B-PP	O
result	result	NN	B-NP	O
for	for	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
dosing	dosing	NN	I-NP	O
management/adjustments	management/adjustment	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

PCP	PCP	NN	B-NP	O
to	to	TO	B-PP	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
HgA1C	HgA1C	NN	B-NP	B-protein
and	and	CC	I-NP	O
manage	manage	NN	I-NP	O
DM	DM	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Recommend	Recommend	VB	B-VP	O
pt	pt	NN	B-NP	O
be	be	VB	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
STATIN	STATIN	NN	B-NP	B-protein
and	and	CC	I-NP	O
LFTs	LFT	NNS	I-NP	B-protein
followed	follow	VBD	B-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
daily	daily	RB	B-ADVP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
for	for	IN	B-PP	O
strength/conditioning	strength/conditione	VBG	B-VP	O
/	/	SYM	B-NP	O
ambulatory	ambulatory	JJ	I-NP	O
/	/	SYM	I-NP	O
safety	safety	NN	I-NP	O
needs	need	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
ROCKAFELLOW	ROCKAFELLOW	NNP	B-NP	O
,	,	,	O	O
CARMEN	CARMEN	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
PA	PA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HS92	HS92	NN	I-NP	B-DNA
-RRB-	-RRB-	NN	I-NP	O
4/15/06	4/15/06	CD	I-NP	O
@	@	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
11	11	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

